RxDoctor Payments Data

Amy Woehrmann

Emergency Medicine · Houston, TXNPI 1043230931

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (48.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 73.0% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $5,904, 5.0 times the $1,172 reported in 2019. Among emergency medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,705in general payments, 2019–2025

Across 270 payments — averaging $72.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$14K
  • Merz North America, Inc.$2K
  • Galderma Laboratories, L.p.$2K
  • Revance Therapeutics, Inc.$1K
  • Apollo Endosurgery US Inc$39

What the payments were for

  • Speaking & faculty fees$8,33142%
  • Travel & lodging$1,7929%
  • Food & beverage$9,54948%
  • Education$340%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,705 in reported general payments places this provider in the 95th percentile of 3,952 emergency medicine providers in Texas.

See all emergency medicine providers in Texas →

Other emergency medicine in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →